Top Markets
Coin of the day
Lucira Health, Inc. Lucira Health, Inc.

Lucira Health, Inc.

LHDX
Rangering i aksjer #33746
Lucira Health, Inc. is a medical technology enterprise dedicated to the... Lucira Health, Inc. is a medical technology enterprise dedicated to the development and commercialization of diagnostic test kits for infectious diseases. The company has innovated a platform capable of providing molecular testing capabilities. Among its current product offerings is the LUCIRA COVID-19 All-In-One Test Kit, and it is also progressing with the development of diagnostic solutions for influenza A and B viruses. Lucira Health holds a patent license agreement with Eiken Chemical Co., Ltd., alongside technical and manufacturing service agreements with Jabil, Inc. and Jabil MSA, respectively. Founded in 2013, the company operated as DiAssess Inc. until January 2020 when it rebranded to Lucira Health, Inc. Its main offices are situated in Emeryville, California.
Aksjekurs
$0.4523
Sist synkronisert: 2023-03-03
Markedsverdi
$6.97M
Endring (1 dag)
-19.23%
Endring (1 år)
0.00%
Land
US
Handel Lucira Health, Inc. (LHDX)

Kategori

Antall utestående aksjer for Lucira Health, Inc. (LHDX)
Antall utestående aksjer per August 2026: 0
Ifølge Lucira Health, Inc. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 0. Ved slutten av August 2026 hadde selskapet 0 utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Lucira Health, Inc. (LHDX) fra 2026 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
Ikke nok data for de angitte datoene.
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
1.74B -
US
383.50M -
US
1.28B -
IE
1.48B -
US
576.40M -
US